Article

Protein arginine methyltransferase-5 Selective Inhibitor Enhances Therapeutic Effects of Cisplatin on Lung Cancer Cells

2020-02-24

Abstract excerpt

<title>Abstract</title> <p>Background Lung cancer is the most common cancer globally. Protein arginine methyltransferase 5 (PRMT5) is identified to be involved in gene transcriptional regulation and cell division. PRMT5 is highly expressed in lung adenocarcinoma, hepatocellular carcinoma, and melanoma, raising evidence that PRMT5 might be involved in tumorigenesis. The aim of this study is to examine potential se...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dac532c0-bef1-546e-bb33-fa75c488d206
DOI: 10.21203/rs.2.24400/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Protein arginine methyltransferase-5 Selective Inhibitor Enhances Therapeutic Effects of Cisplatin on Lung Cancer CellsDOI 10.21203/rs.2.24400/v1Read

Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinomaSemantic proximity Read

Pan-Cancer Analysis of Molecular Characteristics and Oncogenic Role of PRMT5 in Human CancersSemantic proximity Read

Regulation of cisplatin resistance in lung cancer by epigenetic mechanismsSemantic proximity Read

PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinomaSemantic proximity Read

Designing Effective Protein Lysine and Arginine Methyltransferase Inhibitors for Chemotherapeutic TargetingSemantic proximity Read

Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectivesSemantic proximity Read

PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cellsSemantic proximity Read

PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.Semantic proximity Read

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.Semantic proximity Read

PRMT5-exacerbating tumor stemness and immunosuppression confer a novel immunotherapeutic vulnerability in aggressive prostate cancerSemantic proximity Read

Protein Arginine Methyltransferase 5 (PRMT5) Mutations in Cancer Cells.Semantic proximity Read

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtypeSemantic proximity Read